ASCEND BY NTHRYS
Research Abroad Products

Applied Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
MRD Monitoring Platform for Cancer Treatment Response
An enterprise software solution that tracks minimal residual disease through serial blood sampling to assess chemotherapy efficacy and predict relapse risk in real time. Monetizes through clinical trial services, post-treatment surveillance subscriptions, and integration with electronic health record systems.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Next-Generation cfDNA Sequencing Service Bundle
A full-service commercial offering combining sample collection, deep DNA sequencing, and AI-powered variant interpretation for comprehensive cancer genomics profiling. Builds revenue through per-test fees, volume discounts for hospital networks, and annual managed care contracts with health systems.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
AI-Powered Cancer Risk Stratification from Blood Biomarkers
A machine learning platform that integrates multiple cfDNA metrics, protein biomarkers, and epigenetic signatures to predict cancer likelihood and progression trajectories. Captures market value through B2B licensing to diagnostic labs, employer wellness programs, and insurance company risk assessment contracts.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Immunotherapy Response Prediction using Liquid Biopsy Data
A proprietary analytics platform that combines ctDNA dynamics, immune cell profiling, and tumor mutational burden from blood to forecast checkpoint inhibitor effectiveness pre-treatment. Generates revenue through pharmaceutical partnerships, clinical trial support services, and integrated diagnostic bundles with oncology centers.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Multi-Cancer Panel Testing with Commercial Grade Sensitivity
A CLIA-certified laboratory service offering simultaneous detection of ten to twenty cancer types from a single blood draw using standardized liquid biopsy protocols. Monetizes through per-panel pricing, health insurance reimbursement claims, employer health screening contracts, and direct-to-consumer testing options.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Real-Time Tumor Heterogeneity Mapping via Liquid Biopsies
An advanced genomics platform that characterizes multiple tumor clones and subpopulations from circulating DNA to guide adaptive treatment strategies and combination therapy selection. Delivers commercial value through precision medicine partnerships, oncology treatment centers, clinical research organization collaborations, and institutional licensure fees.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
White-Label Liquid Biopsy Testing Infrastructure and Operations
A turn-key commercial platform providing sequencing, data analysis, quality assurance, and regulatory compliance for healthcare providers and diagnostic companies to launch private-label cancer blood tests. Enables partners to build recurring testing revenue while the platform provider captures infrastructure fees, per-sample processing charges, and annual maintenance contracts.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Fragmentation Pattern Analytics for Cancer DNA Detection Optimization
A specialized bioinformatics tool that analyzes nucleosome positioning and DNA fragment length signatures in cfDNA to improve cancer detection specificity and reduce false positives. Monetizes through diagnostic kit sales, technology licensing to sequencing equipment manufacturers, and integration partnerships with major clinical laboratory networks.
Cancer Liquid Biopsy Applied Genomics Platforms Click to view more details →
Cloud-Based LIMS Platform for High-Throughput Genomic Sequencing
A scalable SaaS LIMS solution that manages sample tracking, data processing, and quality control workflows for genomic laboratories operating at enterprise scale. Enables labs to reduce operational costs by 40% while improving throughput and compliance reporting for regulatory bodies.
Applied Genomics LIMS & Pipeline Development Click to view more details →
AI-Powered Variant Calling and Annotation Pipeline Software
Proprietary bioinformatics tool that automates variant detection, classification, and clinical interpretation using machine learning models trained on millions of genomic datasets. Generates premium subscription revenue through API access, licensing to clinical labs, and per-sample processing fees.
Applied Genomics LIMS & Pipeline Development Click to view more details →
Real-Time Sample Tracking and Chain-of-Custody Management System
Enterprise dashboard integrating barcode scanning, IoT sensors, and blockchain verification to ensure complete sample provenance throughout genomic testing workflows. Reduces liability costs by eliminating sample mix-ups while commanding premium pricing in regulated diagnostic markets.
Applied Genomics LIMS & Pipeline Development Click to view more details →
Multi-Omics Data Integration and Visualization Platform
Unified SaaS tool that consolidates genomics, transcriptomics, proteomics, and metabolomics datasets with interactive visualization and statistical analysis capabilities. Creates recurring revenue through tiered subscription models and white-label licensing to research institutions and pharmaceutical companies.
Applied Genomics LIMS & Pipeline Development Click to view more details →